NEW YORK (GenomeWeb) – Qiagen said this week that it will be begin offering a quality control set and verification data with its GeneReader NGS System. The company will integrate Horizon Discovery Group's industry-standard reference control data set into the GeneReader NGS workflow. Further, Qiagen said its GeneRead QIAact Actionable Insights Tumor Panel has demonstrated accuracy, consistency, and reliability in testing compared with Horizon's control data.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.